Objective To determine whether memory tasks with demonstrated sensitivity to hippocampal
function can detect variance related to preclinical Alzheimer disease (AD) biomarkers, we …

Background and purpose Paclitaxel, a widely used anti-cancer drug, is frequently
associated with prolonged and severe peripheral neuropathies (PIPN), associated with …

Increased fMRI activation in the hippocampus is recognized as a signature characteristic of
the amnestic mild cognitive impairment (aMCI) stage of Alzheimer's disease (AD). Previous …

The thalamus is a central integration structure in the brain, receiving and distributing information
among the cerebral cortex, subcortical structures, and the peripheral nervous system. …

Background Despite the increasing uptake of information and communication technologies (ICT)
within healthcare services across developing countries, community healthcare workers (…

Rhizomelic chondrodysplasia punctata type 1 is a peroxisome biogenesis disorder with the
clinical features of rhizomelia, abnormal epiphyseal calcifications, congenital cataracts, and …

Purpose: Cystinosis is caused by a deficiency in the lysosomal cystine transporter,
cystinosin (CTNS gene), resulting in cystine crystal accumulation in tissues. In eyes, crystals …

The entorhinal cortex is the site of some of the earliest pathological changes in Alzheimer's
disease, including neuronal, synaptic and volumetric loss. Specifically, the lateral entorhinal …

Background We have developed the bispectral electroencephalography (BSEEG) method
for detection of delirium and prediction of poor outcomes. Aims To improve the BSEEG …

Anti-estrogens or aromatase inhibitors in combination with cyclin-dependent kinase 4 and 6
(CDK4/6) inhibitors are the current standard of care for estrogen receptor-positive (ER+) Her-…